Immunovant Inc. (IMVT)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
31. 15
+0.23
+0.74%
$
6.86B Market Cap
- P/E Ratio
- Div Yield
1,850,851 Volume
-1.77 Eps
$ 30.92
Previous Close 
Want to track IMVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IMVT earnings report is expected in 1 days (4 Jun 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IMVT Earnings Reports FAQ
What is the earnings per share (EPS) for IMVT?
The current EPS is -1.77.
What is the company's earnings growth rate?
Immunovant Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-06-04, based on the IMVT's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Immunovant Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IMVT at this time, as Immunovant Inc has no recent EPS data to calculate it.
